Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma

We previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucida...

Full description

Bibliographic Details
Main Authors: Ana Todorović, Snežana Pejić, Ljubica Gavrilović, Ivan Pavlović, Vesna Stojiljković, Nataša Popović, Snežana B. Pajović
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/8/4/97
_version_ 1797710256766189568
author Ana Todorović
Snežana Pejić
Ljubica Gavrilović
Ivan Pavlović
Vesna Stojiljković
Nataša Popović
Snežana B. Pajović
author_facet Ana Todorović
Snežana Pejić
Ljubica Gavrilović
Ivan Pavlović
Vesna Stojiljković
Nataša Popović
Snežana B. Pajović
author_sort Ana Todorović
collection DOAJ
description We previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucidate the mechanism of the observed changes, we examined protein and mRNA levels of copper-zinc superoxide dismutase (CuZnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and transcription factor Nrf2. We also examined correlations of AOE expression with AOE activity, lipid hydroperoxides (LOOH) level, and level of Nrf2. Our results showed decreased CuZnSOD, CAT, and Nrf2 levels, and increased GPx and GR levels in hyperplasias, while in patients with adenocarcinoma, the level of CAT was decreased and GR was increased, compared to benign groups. Similar changes in mRNA levels were also detected, indicating predominantly translational control of the AOE expression. The positive correlation of enzyme expression/activity was recorded for CuZnSOD, GPx, and GR, but only among groups with benign diseases. Only GR and GPx expressions were positively correlated with LOOH. Nrf2 protein was positively correlated with mRNA levels of CuZnSOD and GR. Observed results indicate involvement of diverse redox mechanisms in etiopathogenesis of different gynecological diseases, and may improve redox-based approaches in current clinical practice.
first_indexed 2024-03-12T06:49:33Z
format Article
id doaj.art-b70b7a3abf1e46ecafdaee9dd7b11f4b
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-12T06:49:33Z
publishDate 2019-04-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-b70b7a3abf1e46ecafdaee9dd7b11f4b2023-09-03T00:23:31ZengMDPI AGAntioxidants2076-39212019-04-01849710.3390/antiox8040097antiox8040097Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and AdenocarcinomaAna Todorović0Snežana Pejić1Ljubica Gavrilović2Ivan Pavlović3Vesna Stojiljković4Nataša Popović5Snežana B. Pajović6Laboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaLaboratory of Molecular Biology and Endocrinology, “Vinča” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11001 Belgrade, SerbiaWe previously found that compared to patients with benign uterine diseases (polyps, myomas), patients with premalignant (hyperplasia simplex and complex) and malignant (adenocarcinoma) lesions had enhanced lipid peroxidation and altered uterine antioxidant enzyme (AOE) activities. To further elucidate the mechanism of the observed changes, we examined protein and mRNA levels of copper-zinc superoxide dismutase (CuZnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and transcription factor Nrf2. We also examined correlations of AOE expression with AOE activity, lipid hydroperoxides (LOOH) level, and level of Nrf2. Our results showed decreased CuZnSOD, CAT, and Nrf2 levels, and increased GPx and GR levels in hyperplasias, while in patients with adenocarcinoma, the level of CAT was decreased and GR was increased, compared to benign groups. Similar changes in mRNA levels were also detected, indicating predominantly translational control of the AOE expression. The positive correlation of enzyme expression/activity was recorded for CuZnSOD, GPx, and GR, but only among groups with benign diseases. Only GR and GPx expressions were positively correlated with LOOH. Nrf2 protein was positively correlated with mRNA levels of CuZnSOD and GR. Observed results indicate involvement of diverse redox mechanisms in etiopathogenesis of different gynecological diseases, and may improve redox-based approaches in current clinical practice.https://www.mdpi.com/2076-3921/8/4/97antioxidant enzymespolypsmyomahyperplasiaadenocarcinoma
spellingShingle Ana Todorović
Snežana Pejić
Ljubica Gavrilović
Ivan Pavlović
Vesna Stojiljković
Nataša Popović
Snežana B. Pajović
Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
Antioxidants
antioxidant enzymes
polyps
myoma
hyperplasia
adenocarcinoma
title Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
title_full Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
title_fullStr Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
title_full_unstemmed Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
title_short Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
title_sort expression of antioxidant enzymes in patients with uterine polyp myoma hyperplasia and adenocarcinoma
topic antioxidant enzymes
polyps
myoma
hyperplasia
adenocarcinoma
url https://www.mdpi.com/2076-3921/8/4/97
work_keys_str_mv AT anatodorovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT snezanapejic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT ljubicagavrilovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT ivanpavlovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT vesnastojiljkovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT natasapopovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma
AT snezanabpajovic expressionofantioxidantenzymesinpatientswithuterinepolypmyomahyperplasiaandadenocarcinoma